Time and Labor Costs Associated With Administration of Intravenous Bisphosphonates for Breast or Prostate Cancer Patients With Metastatic Bone Disease: A Time and Motion Study

Hospital Practice ◽

10.3810/hp.2014.04.1102 ◽

2014 ◽

Vol 42 (2) ◽

pp. 38-45 ◽

Author(s):

Feng Xie ◽

Robert B. Hopkins ◽

Natasha Burke ◽

Mohdhar Habib ◽

Carlo De Angelis ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Labor Costs ◽

Time And Motion Study ◽

Time And Motion ◽

Motion Study ◽

Intravenous Bisphosphonates

Download Full-text

Results From a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease From Italian Sites

Value in Health ◽

10.1016/j.jval.2015.09.1331 ◽

2015 ◽

Vol 18 (7) ◽

pp. A485-A486 ◽

Author(s):

P Pedrazzoli ◽

A Caraceni ◽

A Beano ◽

V Adamo ◽

F Testore ◽

...

Keyword(s):

Zoledronic Acid ◽

Bone Disease ◽

Intravenous Infusion ◽

Subcutaneous Injection ◽

Metastatic Bone Disease ◽

Time And Motion Study ◽

Time And Motion ◽

Download Full-text

A Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease in Belgium

Value in Health ◽

10.1016/j.jval.2015.09.1330 ◽

2015 ◽

Vol 18 (7) ◽

pp. A485 ◽

Author(s):

J Body ◽

J Mebis ◽

M Peeters ◽

T Besse-Hammer ◽

V Fikkert ◽

...

Keyword(s):

Zoledronic Acid ◽

Bone Disease ◽

Intravenous Infusion ◽

Subcutaneous Injection ◽

Metastatic Bone Disease ◽

Time And Motion Study ◽

Time And Motion ◽

Download Full-text

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries

Supportive Care in Cancer ◽

10.1007/s00520-017-3697-5 ◽

2017 ◽

Vol 25 (9) ◽

pp. 2823-2832 ◽

Author(s):

Jean-Jacques Body ◽

Francesca Gatta ◽

Erwin De Cock ◽

Sunning Tao ◽

Persefoni Kritikou ◽

...

Keyword(s):

Zoledronic Acid ◽

Bone Disease ◽

Intravenous Infusion ◽

Subcutaneous Injection ◽

Metastatic Bone Disease ◽

European Countries ◽

Time And Motion Study ◽

Time And Motion ◽

Download Full-text

1617 An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: Results from Belgium and Germany

European Journal of Cancer ◽

10.1016/s0959-8049(16)30705-5 ◽

2015 ◽

Vol 51 ◽

pp. S244

Author(s):

J.J. Body ◽

F. Gatta ◽

M. Peteers ◽

P. Wimberger ◽

J. Mebis ◽

...

Keyword(s):

Zoledronic Acid ◽

Bone Disease ◽

Intravenous Infusion ◽

Subcutaneous Injection ◽

Metastatic Bone Disease ◽

Time And Motion Study ◽

Time And Motion ◽

Download Full-text

A time-in-motion study of oral ibandronate versus iv zoledronic acid for treatment of metastatic bone disease in breast cancer patients

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6123 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6123-6123 ◽

Author(s):

A. Wardley ◽

J.-J. Body ◽

M. Neary

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Download Full-text

PCN9 ATIME-IN-MOTION STUDY OF ORAL IBANDRONATE VERSUS IV ZOLEDRONIC ACID FOR THE TREATMENT OF METASTATIC BONE DISEASE IN BREAST CANCER PATIENTS IN THE UK

Value in Health ◽

10.1016/s1098-3015(10)65743-9 ◽

2004 ◽

Vol 7 (6) ◽

pp. 671-672

Author(s):

A Wardley ◽

JJ Body ◽

M Neary ◽

G Lewis

Keyword(s):

Breast Cancer ◽

Zoledronic Acid ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Breast Cancer Patients ◽

Motion Study ◽

Download Full-text

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease

Prostate Cancer and Prostatic Diseases ◽

10.1038/pcan.2008.10 ◽

2008 ◽

Vol 12 (1) ◽

pp. 94-99 ◽

Author(s):

M Tucci ◽

A Mosca ◽

G Lamanna ◽

F Porpiglia ◽

M Terzolo ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Bone Disease ◽

Calcium Metabolism ◽

Prognostic Significance ◽

Metastatic Bone Disease ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

Download Full-text

A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial

International Journal of Clinical Oncology ◽

10.1007/s10147-016-1037-2 ◽

2016 ◽

Vol 22 (1) ◽

pp. 166-173 ◽

Author(s):

Tomomi Kamba ◽

◽

Toshiyuki Kamoto ◽

Shinichiro Maruo ◽

Takashi Kikuchi ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Phase Iii ◽

Controlled Study ◽

Randomized Controlled ◽

Combined Androgen Blockade ◽

Androgen Blockade

Download Full-text

669 A phase III, multicenter, randomized, controlled study of maximum androgen blockade with vs without zoledronic acid in prostate cancer patients with metastatic bone disease: Results of main secondary endpoints in ZAPCA trial

European Urology Supplements ◽

10.1016/s1569-9056(15)60662-5 ◽

2015 ◽

Vol 14 (2) ◽

pp. e669

Author(s):

T. Kamba ◽

T. Kamoto ◽

Y. Shimizu ◽

S. Namiki ◽

K. Fujimoto ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Phase Iii ◽

Controlled Study ◽

Randomized Controlled ◽

Secondary Endpoints ◽

Androgen Blockade

Download Full-text

Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

Cancer Management and Research ◽

10.2147/cmar.s25537 ◽

2013 ◽

pp. 1 ◽

Author(s):

Harrison ◽

Daniel George ◽

Wong ◽

Andrew Armstrong

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Bone Disease ◽

Metastatic Bone Disease ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Download Full-text